1. Volume 63, Issue 6, Pages 2222-2229 (June 2003)
Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS 
Rachel A. Burdick, Jennifer L. Bragg-Gresham, John D. Woods, Sara A. Hedderwick, Kiyoshi Kurokawa, Christian Combe, Akira Saito, John Labrecque, Friedrich K. Port, Eric W. Young 
Kidney International 
Volume 63, Issue 6, Pages (June 2003)
DOI: /j x
Copyright © 2003 International Society of Nephrology Terms and Conditions

2. Figure 1
Variation in hepatitis B virus (HBV) prevalence by patient's time on dialysis. The mean time on ESRD was 4.9 years, with a SD of 5.4 years.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

3. Figure 2
Distribution of hepatitis B virus (HBV) prevalence by facility. Mean HBV prevalence was 3.1%, with a median of 2.0%. The percentage of facilities with an HBV prevalence of 0% to 5% was 77%.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

4. Figure 3
Distribution of hepatitis B virus (HBV) seroconversion rates by facility. In 78.1% of facilities, the mean seroconversion rate was 0 seroconversions per 100 patient-years.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions